While tirzepatide does not directly target reproductive hormones, the significant weight loss and metabolic changes it produces can influence the hypothalamic-pituitary-ovarian axis that regulates menstruation
Out of that conversation comes a recommendation
Already a subscriber
Specifications Strength 5 mg/vial Form Lyophilized powder Presentation Single-dose sterile vial Purity 98% by HPLC Testing Identity, potency, sterility Storage Refrigerate, protect from light Release Certificate of analysis per lot Prescribing information How AOD-9604 is supplied
Also identified was increased risk of abdominal pain, gastroesophageal reflux disease (GERD), gastritis, non-infectious gastroenteritis, gastroparesis, diverticulosis, diverticulitis, low blood pressure, fainting, sleep disturbances, headaches, arthritis and joint pain, tendinitis, and kidney problems (interstitial nephritis and nephrolithiasis), gallstone formation and gallbladder inflammation
J Clin Invest (1998) 101(7):142130